Pennsylvania HR 124: A Resolution designating the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania.
Status: Referred to Health (as of 2025-03-17)
State: Pennsylvania · Session: 2025-2026 · Bill: HR 124
Sponsors: Jeanne Mcneill, Anthony Bellmon, Ben Waxman, Benjamin Sanchez, Carol Hill-Evans, Dan Williams, Daniel Deasy, David Zimmerman, Ed Neilson, G. Roni Green, Greg Vitali, Jill Cooper, Joe Ciresi, Johanny Cepeda-Freytiz, Jose Giral, Joseph Hohenstein, Keith Greiner, Liz Hanbidge, Maureen Madden, Melissa Cerrato, Michael Schlossberg, Nikki Rivera, Robert Freeman, Russ Diamond, Steve Samuelson
Bill Text
PRINTER'S NO. 994 THE GENERAL ASSEMBLY OF PENNSYLVANIA HOUSE RESOLUTION No. 124 Session of 2025 INTRODUCED BY McNEILL, FREEMAN, GREINER, SANCHEZ, HILL-EVANS, MADDEN, VITALI, WAXMAN, SAMUELSON, MALAGARI, COOPER, GIRAL, HANBIDGE, DIAMOND, NEILSON, ZIMMERMAN, RIVERA, D. WILLIAMS, BELLMON, CERRATO, HOHENSTEIN AND SCHLOSSBERG, MARCH 17, 2025 REFERRED TO COMMITTEE ON HEALTH, MARCH 17, 2025 A RESOLUTION Designating the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania. WHEREAS, The prostate is a small gland found only in men and located below the bladder; and WHEREAS, In some cases, prostate cancer can make the prostate enlarged; and WHEREAS, Prostate Cancer Research, a nonprofit organization under the National Cancer Research Institute, reports that the risk of prostate cancer increases with age with most cases diagnosed in men over 50 years of age; and WHEREAS, According to the Prostate Conditions Education Council, 1 in 8 American men will get prostate cancer and 1 in 41 men will die from prostate cancer; and WHEREAS, The American Cancer Society estimates that more than 13,000 new cases of prostate cancer will be diagnosed in 2025 in Pennsylvania; and WHEREAS, The American Cancer Society estimates that 1,500 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 Pennsylvanians will die of prostate cancer in 2025; and WHEREAS, The Centers for Disease Control and Prevention describes symptoms of prostate cancer that include difficulty starting urination, weak or interrupted flow of urine, trouble emptying the bladder completely, pain or burning during urination, blood in the urine and pain in the back, hips or pelvis; and WHEREAS, Prostate cancer can be dormant in a person's body for up to 20 years without symptoms, increasing the chance that a person may be sick without the person's knowledge; and WHEREAS, The American Cancer Society recommends that men with an average risk of prostate cancer start screening for prostate cancer at 50 years of age; and WHEREAS, For men at a high risk of developing prostate cancer and men who have a first-degree relative diagnosed with prostate cancer at an early age, screening should begin at 45 years of age; and WHEREAS, For men at even greater risk, including those with more than one first-degree relative who had prostate cancer at an early age, screening should begin at 40 years of age; and WHEREAS, Men should consult with their physician about the benefits of screening for prostate cancer; and WHEREAS, There are two tests used by physicians to screen for prostate cancer: a prostate-specific antigen test, which measures the level of prostate-specific antigen in the blood, and a digital rectal examination, which detects abnormalities of the prostate; and WHEREAS, If abnormalities are noted from either screening, a biopsy may be recommended to assist in diagnosing potential prostate cancer; and 20250HR0124PN0994 - 2 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 WHEREAS, In the 119th Session of the United States Congress, H.R. 1300 was introduced to provide prostate cancer screenings and prevention by requiring group health plans and health insurance policies to provide health insurance coverage of preventive prostate cancer screenings, without cost-sharing, for men with a personal or family history of prostate cancer; and WHEREAS, If Congress were to pass H.R. 1300, men with federally regulated and state-regulated health coverage could receive this important and possibly lifesaving care; therefore be it RESOLVED, That the House of Representatives of the Commonwealth of Pennsylvania designate the month of September 2025 as "Prostate Cancer Awareness Month" in Pennsylvania; and be it further RESOLVED, That the House of Representatives of the Commonwealth of Pennsylvania urge the Congress of the United States to support H.R. 1300; and be it further RESOLVED, That copies of this resolution be transmitted to the presiding officers of each house of Congress and each member of Congress from Pennsylvania. 20250HR0124PN0994 - 3 - 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
View Pennsylvania HR 124 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.